Bruce D Gelb, MD
img_Bruce D Gelb
DIRECTOR MINDICH CHILD HEALTH AND DEVELOPMENT INSTITUTE
PROFESSOR | Pediatrics, Cardiology
PROFESSOR | Genetics and Genomic Sciences
Are you a patient?
Specialties
Pediatrics, Pediatric Cardiology
Research Topics
Cardiovascular, Gene Discovery, Human Genetics and Genetic Disorders, Pediatrics, Signal Transduction, Stem Cells, Transgenic Mice
Multi-Disciplinary Training Area
Development Regeneration and Stem Cells [DRS], Genetics and Genomic Sciences [GGS]

Specific Clinical/Research Interests:
Genetics of congenital heart defects; Noonan syndrome and related disorders; Gain-of-function RAS signaling

Genetic Counselor: Meghan Mac Neal

Postdoctoral Fellows: Se-Yeon Lee, Kathryn Manheimer

Predoctoral Students: Felix Richter, Nelson Rodriguez

Research Personnel: Jian Zhang, Simon Ng, Jared Gatto, Tara Keshavarz, Yahaira Mendez


Summary of Research Studies:


The Gelb research group is focused on disease gene discovery using genomic techniques and characterization of the biological roles of such genes in disease pathogenesis. The focus of the laboratory currently is on those traits that are associated with heart malformations. In the past, we have identified disease genes for Char and Noonan syndromes. The former is TFAP2B, which encodes a transcription factor of the AP-2 family, and the latter include PTPN11, KRAS, SOS1, SOS2, RAF1 and SHOC2. We are studying the roles of these disease genes in normal developmental and homeostatic processes as well as in disease pathogenesis. We are actively studying additional human genetic traits, both simple and complex, to identify additional disease genes with a particular focus on traits with cardiovascular abnormalities. This is being done with next generation sequencing approaches, both whole exome and genome sequencing. Ongoing biologic studies focus on disease modeling using induced pluripotent stem cells, including creating mutations or correcting them with CRISPR technology. We are also studying disease genes and performing drug discovery in Drosophila melanogaster.

MD, University of Rochester School of Medicine/Dentistry

Residency, Pediatrics, Columbia Presbyterian Medical Center

Fellowship, Pediatric Cardiology, Texas Children's Hospital

Certifications

American Board of Pediatrics

2016

Best Doctors

New York Magazine

2015

Best Doctors

New York Magazine

2010

Best Doctors

New York Magazine

Publications

Selected Publications

Recessive genetic contribution to congenital heart disease in 5,424 probands. Weilai Dong, Sheng Chih Jin, Michael C. Sierant, Ziyu Lu, Boyang Li, Qiongshi Lu, Sarah U. Morton, Junhui Zhang, Francesc López-Giráldez, Carol Nelson-Williams, James R. Knight, Hongyu Zhao, Junyue Cao, Shrikant Mane, Peter J. Gruber, Monkol Lek, Elizabeth Goldmuntz, John Deanfield, Alessandro Giardini, Seema Mital, Mark Russell, J. William Gaynor, James F. Cnota, Michael Wagner, Deepak Srivastava, Daniel Bernstein, George A. Porter, Jane Newburger, Amy E. Roberts, Mark Yandell, H. Joseph Yost, Martin Tristani-Firouzi, Richard Kim, Jonathan Seidman, Wendy K. Chung, Bruce D. Gelb, Christine E. Seidman, Richard P. Lifton, Martina Brueckner. Proceedings of the National Academy of Sciences of the United States of America

Deciphering the digenic architecture of congenital heart disease using trio exome sequencing data. Meltem Ece Kars, David Stein, Peter D. Stenson, David N. Cooper, Wendy K. Chung, Peter J. Gruber, Christine E. Seidman, Yufeng Shen, Martin Tristani-Firouzi, Bruce D. Gelb, Yuval Itan. American Journal of Human Genetics

Modeling SMAD2 Mutations in Induced Pluripotent Stem Cells Provides Insights Into Cardiovascular Disease Pathogenesis. Tarsha Ward, Sarah U. Morton, Gabriela Venturini, Warren Tai, Min Young Jang, Joshua Gorham, Dan Delaughter, Lauren K. Wasson, Zahra Khazal, Jason Homsy, Bruce D. Gelb, Wendy K. Chung, Benoit G. Bruneau, Martina Brueckner, Martin Tristani-Firouzi, Steven R. Depalma, Christine Seidman, J. G. Seidman. Journal of the American Heart Association

View All Publications

Bruce Gelb, MD
Cardiovascular Genetics Program

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Gelb during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Think Bioscience

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Think Bioscience

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.